Quality of INR control and switching to non-Vitamin K oral anticoagulants between women and men with atrial fibrillation treated with Vitamin K Antagonists in Spain. A population-based, real-world study.
Aníbal García-SempereIsabel HurtadoDaniel Bejarano-QuisoboniClara Rodríguez-BernalYared Santa-AnaSalvador PeiróGabriel Sanfélix-GimenoPublished in: PloS one (2019)
The quality of INR control of all AF patients treated with VKA in 2015 in our Southern European region was suboptimal, and women were at a higher risk of poor INR control. This reflects sex disparities in care, and programs for improving the quality of oral anticoagulation should incorporate the gender perspective. Clinical inertia may be lying behind the observed low rates of switching in patient with poor INR control.
Keyphrases
- atrial fibrillation
- oral anticoagulants
- healthcare
- polycystic ovary syndrome
- left atrial
- catheter ablation
- left atrial appendage
- palliative care
- type diabetes
- mental health
- metabolic syndrome
- venous thromboembolism
- coronary artery disease
- acute coronary syndrome
- pain management
- percutaneous coronary intervention
- skeletal muscle
- pregnant women
- newly diagnosed
- insulin resistance
- health insurance